ELOPAG 50 MG
Elopag Tablet Eltrombopag Olamine 50 mg Everest Pharmaceuticals Ltd. Also available as: 25 mg Indications Eltrombopag Olamine is indicated in Chronic
HEPANIB 200 MG
Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd. Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with
HERNIX 40 MG
Hernix Tablet Neratinib 40 mg Beacon Pharmaceuticals Ltd. Indications Neratinib is a kinase inhibitor indicated for the extended adjuvant treatment of
IBRUNIB 140 MG
IBRUNIB Strength 140 mg Packing 1 X 30 Capsules (Plastic Container) Storage Store below 30°C. Keep capsules in the original
LARONIB 100 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
LARONIB 25 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
LENVANIX 4 MG
Lenvanix (lenvatinib) 4 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
MEZOXIA 160 MG
Mezoxia Tablet Megestrol Acetate 160 mg Everest Pharmaceuticals Ltd. Indications Megestrol Acetate is indicated for the palliative treatment of advanced carcinoma
NEXATAF 25 MG
Nexataf Tablet Tenofovir Alafenamide 25 mg Everest Pharmaceuticals Ltd. Indications Tenofovir Alafenamide is a hepatitis B virus (HBV) nucleoside analog reverse
OSIMERT 80 MG
DESCRIPTION Osimert 80 mg Osimertinib COMPOSITION Osimert Tablet: Each film coated tablet contains Osimertinib mesylate INN 95.4 mg equivalent to
RESOLAX 1 MG
Resolax Tablet Prucalopride Succinate 1 mg Everest Pharmaceuticals Ltd. Indications Prucalopride is indicated for symptomatic treatment of chronic constipation in adults
SUNITIX 50 MG
Sunitix Capsule Sunitinib 50 mg Beacon Pharmaceuticals Ltd. Indications Gastrointestinal Stromal Tumor (GIST): Sunitinib is indicated for the treatment of gastrointestinal